Stellenbeschreibung
Postdoctoral Researcher – CAR T-Cell Development and Tumor Immunology (m/f/d)
(m/f/d) Workplace Campus Innenstadt Working hours Full time Institution Institut für Klinische Pharmakologie Department Cell Therapy and Tumor Immunology Date of entry 01.01.2027 Application deadline 15.12.2026 Reference Number 2026-K-0446
The Hospital of the University of Munich, Germany, is one of the largest and most competitive university hospitals in Germany and Europe. 48 specialized hospitals, departments and institutions harbouring excellent research and education provide patient care at the highest medical level with around 12.000 employees.
Scope of duties
Develop and optimize CAR constructs and support their transfer into a scalable retroviral vector system
Generate and characterize CAR T cells and assess their functionality in vitro using AML cell lines and primary patient samples
Investigate CAR T-cell cytotoxicity, activation, differentiation, and proliferation.
Evaluate potential off-target effects and hematopoietic toxicity using humanized mouse models and healthy human tissue explant models
Analyze experimental data, document results, and contribute to scientific publications and preclinical safety evaluation
Collaborate with interdisciplinary research teams within the CARAMeL consortium
Our requirements
PhD, MD, PharmD, DVM, or an equivalent doctoral degree in immunology, molecular or cell biology, biochemistry, biomedical sciences, or a related field
Strong experimental research experience and a good publication record
Solid knowledge of immunology and cell biology, with practical experience in cell culture and functional assays
Experience in one or more of the following areas is highly desirable: CAR T-cell engineering, viral vector technology, flow cytometry, or preclinical in vivo models
Strong analytical skills and an independent, structured approach to research
High motivation, initiative, and the ability to work collaboratively in an international research environment
Excellent written and spoken English Our offer Contract duration: 2 years fixed-term
The Institute of Clinical Pharmacology at LMU University Hospital Munich offers an interdisciplinary research environment at the interface of experimental immunology, innovative cell therapies, and translational medicine
The research group of Prof. Dr. Sebastian Kobold focuses on developing novel cancer immunotherapies, particularly cellular therapies and antibody-based approaches
This position is part of the CARAMeL consortium, funded by the German Cancer Consortium (DKTK). The project aims to advance an innovative CAR T-cell therapy for patients with relapsed or refractory acute myeloid leukemia (AML). A key objective is to improve therapeutic efficacy while minimizing damage to healthy hematopoietic stem and progenitor cells
The successful candidate will contribute to translating the CAR technology into a scalable retroviral vector system and investigating the functionality and preclinical safety of the resulting CAR T cells. The work will be conducted in close collaboration with national and international research partners
Offers and services of the employer Further education and training Job ticket Company pension scheme Discounts Childcare services Staff accommodation (if available) Mobile work (if suitable) Mrs. Putz, Jacqueline +49 89 4400 57301 Application format Please use the Online-Form for your application
Disabled persons will be preferentially considered in case of equal qualification. Presentation costs cannot be refunded.
Please note that we cannot reimburse travel expenses incurred through interviews.
We ask you for your understanding that postal applications will not be returned, but will be destroyed in accordance with data protection regulations. The data usage information also applies to postal applications
Anzeige nicht mehr aktuell? Stelle austragen



